Skip to main content
. Author manuscript; available in PMC: 2024 Nov 26.
Published in final edited form as: Respirology. 2022 Dec 19;28(5):475–483. doi: 10.1111/resp.14438

Table 2.

Nodule detection on nCLE-imaging compared to the diagnostic adequacy of ROSE, TBNA cytology, biopsy histology and final diagnosis

Patient number Radial EBUS Signal Repositioning nCLE-imaging TBNA ROSE TBNA cytology Forceps biopsy histology Final diagnosis
1 Eccentric Yes + + Lymphoplasmatic infiltrate
2 Eccentric Yes + + + + Thyroid carcinoma
3 Concentric No + + + + Adenocarcinoma
4 Eccentric No + + + n/a Adenocarcinoma
5 Eccentric Yes + + n/a Squamous cell carcinoma
6 Eccentric Yes + + Renal cell carcinoma
7 Eccentric Yes + + n/a Carcinoid
8 Concentric Yes + Adenocarcinoma
9 Concentric No + + Epithelioid granuloma
10 Eccentric No + + + Adenocarcinoma
11 Eccentric No + + + Melanoma
12 Concentric No + + + + Adenocarcinoma
13 Concentric No + + + Adenocarcinoma
14a Absent Yes n/a Adenocarcinoma
15 Eccentric Yes + Carcinoid
16 Eccentric No + + + n/a Carcinoid
17 Eccentric Yes + + + Adenocarcinoma
18 Eccentric No + + + n/a Carcinoid
19 Concentric No + + + n/a Melanoma
20 Eccentric No + Indeterminateb
Adequacy for lesion detection and diagnosis: 19/20=95% 9/20=45% 12/20=60% 9/13=69%
TBNA+biopsies=16/20=80%

nCLE nodule detection: += nCLE criteria compatible with malignancy, granuloma or inflammation − = absence of nCLE malignancy, granuloma or inflammation criteria. ROSE/TBNA/biopsies; + =tissue specimen shows signs of a malignant or non-malignant diagnosis, − =bronchus epithelium/blood contamination without signs of malignancy or an alternative diagnosis.

a

In one patient with a subsolid nodule, no r-EBUS signal was obtained and nCLE-imaging was unable to detect the nodule.

b

In one patient no final diagnosis was established and the nodule remained stable at 12months follow-up. nCLE= needle based confocal laser endomicroscopy; TBNA= transbronchial needle aspiration; ROSE= rapid onsite evaluation.